LifeStance Health Group, Inc. (LFST)
Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
drawn.
Quarters are the company's own, counted from its financial
year ending 12-31.
Amounts in USD.
Every figure as a table ›
Revenue Quarterly
0
150M
300M
450M
Q3 '21: 173.8M
Q4 '21: 190M
Q1 '22: 203.1M
Q2 '22: 209.5M
Q3 '22: 217.6M
Q4 '22: 229.4M
Q1 '23: 252.6M
Q2 '23: 259.6M
Q3 '23: 262.9M
Q4 '23: 280.6M
Q1 '24: 300.4M
Q2 '24: 312.3M
Q3 '24: 312.7M
Q4 '24: 325.5M
Q1 '25: 333M
Q2 '25: 345.3M
Q3 '25: 363.8M
Q4 '25: 382.2M
Q1 '26: 403.5M
Q2 '26: 435.4M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Operating Income Quarterly
-150M
-100M
-50M
0
50M
100M
150M
Q3 '21: -124.7M
Q4 '21: -113.8M
Q1 '22: -64.9M
Q2 '22: -60.5M
Q3 '22: -38.8M
Q4 '22: -46M
Q1 '23: -34.1M
Q2 '23: -48.4M
Q3 '23: -74.4M
Q4 '23: -32.3M
Q1 '24: -16.8M
Q2 '24: -15.9M
Q3 '24: 47K
Q4 '24: 1.1M
Q1 '25: 1.6M
Q2 '25: -3M
Q3 '25: 7.4M
Q4 '25: 18.1M
Q1 '26: 22.3M
Q2 '26: 30.7M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Net Income Quarterly
-150M
-100M
-50M
0
50M
100M
150M
Q3 '21: -120.5M
Q4 '21: -108M
Q1 '22: -62.3M
Q2 '22: -68.7M
Q3 '22: -37.9M
Q4 '22: -46.7M
Q1 '23: -34.2M
Q2 '23: -45.5M
Q3 '23: -61.6M
Q4 '23: -45M
Q1 '24: -21.1M
Q2 '24: -23.3M
Q3 '24: 709K
Q4 '24: -7.1M
Q1 '25: 709K
Q2 '25: -3.8M
Q3 '25: 1.1M
Q4 '25: 11.7M
Q1 '26: 14.2M
Q2 '26: 23.6M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Operating Cash Flow Quarterly
-35M
0
35M
70M
105M
Q3 '21: -14.2M
Q4 '21: 30.6M
Q1 '22: 3.3M
Q2 '22: 7.8M
Q3 '22: 5.7M
Q4 '22: 35.9M
Q1 '23: -7.9M
Q2 '23: -434K
Q3 '23: -25.4M
Q4 '23: 16.8M
Q1 '24: -21.8M
Q2 '24: 44.1M
Q3 '24: 22.7M
Q4 '24: 62.3M
Q1 '25: -3.1M
Q2 '25: 64.4M
Q3 '25: 27.3M
Q4 '25: 57.6M
Q1 '26: 33.1M
Q2 '26: 99.9M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Free Cash Flow Quarterly
-60M
-30M
0
30M
60M
90M
Q3 '21: -38.2M
Q4 '21: -8M
Q1 '22: -24.6M
Q2 '22: -18M
Q3 '22: -9.4M
Q4 '22: 25.5M
Q1 '23: -15.6M
Q2 '23: -12M
Q3 '23: -35.2M
Q4 '23: 5.4M
Q1 '24: -26.9M
Q2 '24: 39M
Q3 '24: 17.7M
Q4 '24: 56M
Q1 '25: -10.3M
Q2 '25: 56.6M
Q3 '25: 17M
Q4 '25: 46.6M
Q1 '26: 22.3M
Q2 '26: 87.9M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Operating cash flow minus capital expenditure.
Shares Outstanding Quarterly
0
150M
300M
450M
Q2 '21: 313.5K
Q3 '21: 343.4K
Q1 '22: 350.8K
Q2 '22: 353.7K
Q3 '22: 357.5K
Q1 '23: 360.9M
Q2 '23: 363.2M
Q3 '23: 372.5M
Q1 '24: 376.3M
Q2 '24: 379.4M
Q3 '24: 380.4M
Q1 '25: 390.7M
Q2 '25: 386.7M
Q3 '25: 388.9M
Q1 '26: 395.1M
Q2 '26: 387.3M
Q3 '21
Q2 '22
Q1 '23
Q3 '23
Q2 '24
Q1 '25
Q3 '25
Q2 '26
Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.
Not drawn for LFST:
Gross Profit, Cost of Revenue, EPS . Nothing in this filer's XBRL supports
them for the periods asked for. That is a gap in
the filing, not a zero, and drawing a flat line would be an invention.